1. Home
  2. FNWB vs IKNA Comparison

FNWB vs IKNA Comparison

Compare FNWB & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNWB
  • IKNA
  • Stock Information
  • Founded
  • FNWB 1923
  • IKNA 2016
  • Country
  • FNWB United States
  • IKNA United States
  • Employees
  • FNWB N/A
  • IKNA N/A
  • Industry
  • FNWB Banks
  • IKNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FNWB Finance
  • IKNA Health Care
  • Exchange
  • FNWB Nasdaq
  • IKNA Nasdaq
  • Market Cap
  • FNWB 95.2M
  • IKNA 81.6M
  • IPO Year
  • FNWB 2015
  • IKNA 2021
  • Fundamental
  • Price
  • FNWB $11.18
  • IKNA $1.46
  • Analyst Decision
  • FNWB Hold
  • IKNA Buy
  • Analyst Count
  • FNWB 1
  • IKNA 2
  • Target Price
  • FNWB $12.00
  • IKNA $3.00
  • AVG Volume (30 Days)
  • FNWB 17.6K
  • IKNA 173.8K
  • Earning Date
  • FNWB 01-29-2025
  • IKNA 03-11-2025
  • Dividend Yield
  • FNWB 2.57%
  • IKNA N/A
  • EPS Growth
  • FNWB N/A
  • IKNA N/A
  • EPS
  • FNWB N/A
  • IKNA N/A
  • Revenue
  • FNWB $50,900,000.00
  • IKNA $659,000.00
  • Revenue This Year
  • FNWB N/A
  • IKNA N/A
  • Revenue Next Year
  • FNWB $11.60
  • IKNA N/A
  • P/E Ratio
  • FNWB N/A
  • IKNA N/A
  • Revenue Growth
  • FNWB N/A
  • IKNA N/A
  • 52 Week Low
  • FNWB $8.91
  • IKNA $1.22
  • 52 Week High
  • FNWB $16.00
  • IKNA $1.94
  • Technical
  • Relative Strength Index (RSI)
  • FNWB 64.97
  • IKNA 43.06
  • Support Level
  • FNWB $10.80
  • IKNA $1.40
  • Resistance Level
  • FNWB $11.10
  • IKNA $1.48
  • Average True Range (ATR)
  • FNWB 0.22
  • IKNA 0.06
  • MACD
  • FNWB 0.02
  • IKNA 0.00
  • Stochastic Oscillator
  • FNWB 94.03
  • IKNA 50.00

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

Share on Social Networks: